Compartmental distribution of complement activation products in artificial kidneys

Area of Science:

• Nephrology
• Immunology
• Biomaterials Science

Background:

• Hemodialysis can activate the human complement system, leading to the production of anaphylatoxins like C3a and C5a.
• The distribution and fate of these anaphylatoxins within the hemodialysis circuit are not fully understood.
• Understanding membrane-specific complement activation and anaphylatoxin removal is crucial for optimizing hemodialysis procedures.

Purpose of the Study:

• To investigate the compartmental distribution of C3a and C5a during simulated hemodialysis using various membrane types.
• To compare the complement-activating potential and anaphylatoxin adsorption capacity of different hemodialysis membranes.
• To determine how membrane properties influence anaphylatoxin levels in the blood path and dialysate.

Main Methods:

• Simulated hemodialysis experiments were conducted using different hemodialyzer membrane materials (cuprophan, cellulose acetate, polyacrylonitrile).
• Complement activation was assessed by measuring C3a and C5a antigen formation.
• Anaphylatoxin compartmentalization was analyzed by measuring concentrations in the blood path, dialysate, and adsorbed onto the membrane.

Main Results:

• New cuprophan hollow fiber dialyzers showed high complement activation, with C3a and C5a accumulating in the blood path.
• Re-used cuprophan and cellulose acetate membranes exhibited lower complement activation but varying capacities for anaphylatoxin adsorption.
• Polyacrylonitrile membranes demonstrated minimal complement activation and significant adsorption of C3a and C5a from the blood path.

Conclusions:

• Hemodialysis membranes differ significantly in their complement-activating potential and ability to remove circulating anaphylatoxins.
• Polyacrylonitrile membranes appear unique in their low complement activation and high capacity for adsorbing C3a and C5a.
• These findings highlight the importance of membrane selection in managing complement activation and anaphylatoxin levels during hemodialysis.